| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.4 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |